Loading…
POWER Up-Improving pre-exposure prophylaxis (PrEP) uptake among Black cisgender women in the Southern United States: Protocol for a stepped-wedge cluster randomized trial (SW-CRT)
HIV disproportionately affects Black/African American cisgender women (hereafter women) in the United States. Despite its proven effectiveness, pre-exposure prophylaxis (PrEP) for HIV prevention remains vastly under-prescribed to women based on their need. Increasing PrEP uptake and persistence amon...
Saved in:
Published in: | PloS one 2023-05, Vol.18 (5), p.e0285858-e0285858 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c527t-778101d58c7a71f78904d25e572ed314f2293183c884c1ff5880e835b2be1f133 |
---|---|
cites | cdi_FETCH-LOGICAL-c527t-778101d58c7a71f78904d25e572ed314f2293183c884c1ff5880e835b2be1f133 |
container_end_page | e0285858 |
container_issue | 5 |
container_start_page | e0285858 |
container_title | PloS one |
container_volume | 18 |
creator | Ridgway, Jessica P Devlin, Samantha A Friedman, Eleanor E Enaholo, Ososese E Pyra, Maria Hirschhorn, Lisa R Haider, Sadia Ducheny, Kelly Johnson, Amy K |
description | HIV disproportionately affects Black/African American cisgender women (hereafter women) in the United States. Despite its proven effectiveness, pre-exposure prophylaxis (PrEP) for HIV prevention remains vastly under-prescribed to women based on their need. Increasing PrEP uptake and persistence among women is crucial to reducing HIV transmission; however, there have been few studies designed specifically for women. This article describes the study protocol used to assess the feasibility, acceptability, and effectiveness of implementation strategies to improve PrEP uptake and persistence among Black women in the Midwest and South.
PrEP Optimization among Women to Enhance Retention and Uptake (POWER Up) is an evidence-based, woman-focused set of five implementation science strategies that addresses barriers of PrEP utilization at the provider, patient, and clinic levels. POWER Up includes 1) routine PrEP education for patients, 2) standardized provider training, 3) electronic medical record (EMR) optimization, 4) PrEP navigation, and 5) PrEP clinical champions. These strategies will be adapted to specific clinics for implementation, tested via a stepped-wedge trial, and, if effective, packaged for further dissemination.
We will utilize a stepped-wedge cluster randomized trial (SW-CRT) to measure change in PrEP utilization across diverse geographic areas. Preparation for adapting and implementing the bundle of strategies is needed to determine how to tailor them to specific clinics. Implementation challenges will include adapting strategies with the available resources at each site, maintaining stakeholder involvement and staff buy-in, adjusting the study protocol and planned procedures as needed, and ensuring minimal crossover. Additionally, strengths and limitations of each strategy must be examined before, during, and after the adaptation and implementation processes. Finally, the implementation outcomes of the strategies must be evaluated to determine the real-world success of the strategies. This study is an important step toward addressing the inequity in PrEP service delivery and increasing PrEP utilization among Black women in the U.S. |
doi_str_mv | 10.1371/journal.pone.0285858 |
format | article |
fullrecord | <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_2814793279</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_2d391b601455485fa3e91bc88b96d269</doaj_id><sourcerecordid>2815247005</sourcerecordid><originalsourceid>FETCH-LOGICAL-c527t-778101d58c7a71f78904d25e572ed314f2293183c884c1ff5880e835b2be1f133</originalsourceid><addsrcrecordid>eNptUltv0zAUjhCIjcI_QGCJl-4hxZc4cfaCoCpQadKqddUeLdc-6bIldrCTXfhb_EHcrZs2hCzr-Byf7zsXfUnynuAJYQX5fOEGb1Uz6ZyFCaaCx_Mi2Sclo2lOMXv55L2XvAnhAmPORJ6_TvYivswxFvvJn8Xx2ewErbp03nbeXdV2gzoPKdx0LgweouO689tG3dQBjRd-tjhAQ9erS0CqdTH5W6P0JdJ12IA14NG1a8Gi2qL-HNDSDdF4i1a27sGgZa96CIdo4V3vtGtQ5TxSKPTQdWDSazAbQLoZYsAjr6xxbf074npfqwaNl2fp9OT04G3yqlJNgHc7O0pW32en05_p0fGP-fTrUao5Lfq0KATBxHChC1WQqhAlzgzlwAsKhpGsorRkRDAtRKZJVXEhMAjG13QNpCKMjZKP97xd44Lc7TtIKkhWxM3GO0rm9xnGqQvZ-bpV_lY6Vcu7gPMbqXxf6wYkNawk6xyTjPNM8EoxiH6svS5zQ_Mt15ddtWHdgtFge6-aZ6TPf2x9LjfuSsYhS0JzERnGOwbvfg0QetnWQUPTKAtuuGuc06zYymCUfPon9f_jZfdZ2rsQPFSP3RAstyJ8QMmtCOVOhBH24ekkj6AH1bG_kkrbRQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2814793279</pqid></control><display><type>article</type><title>POWER Up-Improving pre-exposure prophylaxis (PrEP) uptake among Black cisgender women in the Southern United States: Protocol for a stepped-wedge cluster randomized trial (SW-CRT)</title><source>PubMed Central Free</source><source>Publicly Available Content Database</source><creator>Ridgway, Jessica P ; Devlin, Samantha A ; Friedman, Eleanor E ; Enaholo, Ososese E ; Pyra, Maria ; Hirschhorn, Lisa R ; Haider, Sadia ; Ducheny, Kelly ; Johnson, Amy K</creator><contributor>Stortz, Johannes</contributor><creatorcontrib>Ridgway, Jessica P ; Devlin, Samantha A ; Friedman, Eleanor E ; Enaholo, Ososese E ; Pyra, Maria ; Hirschhorn, Lisa R ; Haider, Sadia ; Ducheny, Kelly ; Johnson, Amy K ; Stortz, Johannes</creatorcontrib><description>HIV disproportionately affects Black/African American cisgender women (hereafter women) in the United States. Despite its proven effectiveness, pre-exposure prophylaxis (PrEP) for HIV prevention remains vastly under-prescribed to women based on their need. Increasing PrEP uptake and persistence among women is crucial to reducing HIV transmission; however, there have been few studies designed specifically for women. This article describes the study protocol used to assess the feasibility, acceptability, and effectiveness of implementation strategies to improve PrEP uptake and persistence among Black women in the Midwest and South.
PrEP Optimization among Women to Enhance Retention and Uptake (POWER Up) is an evidence-based, woman-focused set of five implementation science strategies that addresses barriers of PrEP utilization at the provider, patient, and clinic levels. POWER Up includes 1) routine PrEP education for patients, 2) standardized provider training, 3) electronic medical record (EMR) optimization, 4) PrEP navigation, and 5) PrEP clinical champions. These strategies will be adapted to specific clinics for implementation, tested via a stepped-wedge trial, and, if effective, packaged for further dissemination.
We will utilize a stepped-wedge cluster randomized trial (SW-CRT) to measure change in PrEP utilization across diverse geographic areas. Preparation for adapting and implementing the bundle of strategies is needed to determine how to tailor them to specific clinics. Implementation challenges will include adapting strategies with the available resources at each site, maintaining stakeholder involvement and staff buy-in, adjusting the study protocol and planned procedures as needed, and ensuring minimal crossover. Additionally, strengths and limitations of each strategy must be examined before, during, and after the adaptation and implementation processes. Finally, the implementation outcomes of the strategies must be evaluated to determine the real-world success of the strategies. This study is an important step toward addressing the inequity in PrEP service delivery and increasing PrEP utilization among Black women in the U.S.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0285858</identifier><identifier>PMID: 37196008</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acquired Immunodeficiency Syndrome - drug therapy ; Adaptation ; Anti-HIV Agents - therapeutic use ; Biology and Life Sciences ; Black or African American ; Black people ; Cisgender ; Clusters ; Computer and Information Sciences ; Disease prevention ; Disease transmission ; Effectiveness ; Electronic health records ; Electronic medical records ; Engineering and Technology ; Female ; Health care networks ; Health risks ; HIV ; HIV Infections - drug therapy ; HIV Infections - prevention & control ; Human immunodeficiency virus ; Humans ; Medicine and Health Sciences ; Optimization ; Patients ; Pre-Exposure Prophylaxis - methods ; Prophylaxis ; Randomized Controlled Trials as Topic ; Study Protocol ; United States ; Utilization</subject><ispartof>PloS one, 2023-05, Vol.18 (5), p.e0285858-e0285858</ispartof><rights>Copyright: © 2023 Ridgway et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</rights><rights>2023 Ridgway et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 Ridgway et al 2023 Ridgway et al</rights><rights>2023 Ridgway et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c527t-778101d58c7a71f78904d25e572ed314f2293183c884c1ff5880e835b2be1f133</citedby><cites>FETCH-LOGICAL-c527t-778101d58c7a71f78904d25e572ed314f2293183c884c1ff5880e835b2be1f133</cites><orcidid>0000-0002-2090-9620</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2814793279/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2814793279?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37196008$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Stortz, Johannes</contributor><creatorcontrib>Ridgway, Jessica P</creatorcontrib><creatorcontrib>Devlin, Samantha A</creatorcontrib><creatorcontrib>Friedman, Eleanor E</creatorcontrib><creatorcontrib>Enaholo, Ososese E</creatorcontrib><creatorcontrib>Pyra, Maria</creatorcontrib><creatorcontrib>Hirschhorn, Lisa R</creatorcontrib><creatorcontrib>Haider, Sadia</creatorcontrib><creatorcontrib>Ducheny, Kelly</creatorcontrib><creatorcontrib>Johnson, Amy K</creatorcontrib><title>POWER Up-Improving pre-exposure prophylaxis (PrEP) uptake among Black cisgender women in the Southern United States: Protocol for a stepped-wedge cluster randomized trial (SW-CRT)</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>HIV disproportionately affects Black/African American cisgender women (hereafter women) in the United States. Despite its proven effectiveness, pre-exposure prophylaxis (PrEP) for HIV prevention remains vastly under-prescribed to women based on their need. Increasing PrEP uptake and persistence among women is crucial to reducing HIV transmission; however, there have been few studies designed specifically for women. This article describes the study protocol used to assess the feasibility, acceptability, and effectiveness of implementation strategies to improve PrEP uptake and persistence among Black women in the Midwest and South.
PrEP Optimization among Women to Enhance Retention and Uptake (POWER Up) is an evidence-based, woman-focused set of five implementation science strategies that addresses barriers of PrEP utilization at the provider, patient, and clinic levels. POWER Up includes 1) routine PrEP education for patients, 2) standardized provider training, 3) electronic medical record (EMR) optimization, 4) PrEP navigation, and 5) PrEP clinical champions. These strategies will be adapted to specific clinics for implementation, tested via a stepped-wedge trial, and, if effective, packaged for further dissemination.
We will utilize a stepped-wedge cluster randomized trial (SW-CRT) to measure change in PrEP utilization across diverse geographic areas. Preparation for adapting and implementing the bundle of strategies is needed to determine how to tailor them to specific clinics. Implementation challenges will include adapting strategies with the available resources at each site, maintaining stakeholder involvement and staff buy-in, adjusting the study protocol and planned procedures as needed, and ensuring minimal crossover. Additionally, strengths and limitations of each strategy must be examined before, during, and after the adaptation and implementation processes. Finally, the implementation outcomes of the strategies must be evaluated to determine the real-world success of the strategies. This study is an important step toward addressing the inequity in PrEP service delivery and increasing PrEP utilization among Black women in the U.S.</description><subject>Acquired Immunodeficiency Syndrome - drug therapy</subject><subject>Adaptation</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Biology and Life Sciences</subject><subject>Black or African American</subject><subject>Black people</subject><subject>Cisgender</subject><subject>Clusters</subject><subject>Computer and Information Sciences</subject><subject>Disease prevention</subject><subject>Disease transmission</subject><subject>Effectiveness</subject><subject>Electronic health records</subject><subject>Electronic medical records</subject><subject>Engineering and Technology</subject><subject>Female</subject><subject>Health care networks</subject><subject>Health risks</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - prevention & control</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Medicine and Health Sciences</subject><subject>Optimization</subject><subject>Patients</subject><subject>Pre-Exposure Prophylaxis - methods</subject><subject>Prophylaxis</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Study Protocol</subject><subject>United States</subject><subject>Utilization</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUltv0zAUjhCIjcI_QGCJl-4hxZc4cfaCoCpQadKqddUeLdc-6bIldrCTXfhb_EHcrZs2hCzr-Byf7zsXfUnynuAJYQX5fOEGb1Uz6ZyFCaaCx_Mi2Sclo2lOMXv55L2XvAnhAmPORJ6_TvYivswxFvvJn8Xx2ewErbp03nbeXdV2gzoPKdx0LgweouO689tG3dQBjRd-tjhAQ9erS0CqdTH5W6P0JdJ12IA14NG1a8Gi2qL-HNDSDdF4i1a27sGgZa96CIdo4V3vtGtQ5TxSKPTQdWDSazAbQLoZYsAjr6xxbf074npfqwaNl2fp9OT04G3yqlJNgHc7O0pW32en05_p0fGP-fTrUao5Lfq0KATBxHChC1WQqhAlzgzlwAsKhpGsorRkRDAtRKZJVXEhMAjG13QNpCKMjZKP97xd44Lc7TtIKkhWxM3GO0rm9xnGqQvZ-bpV_lY6Vcu7gPMbqXxf6wYkNawk6xyTjPNM8EoxiH6svS5zQ_Mt15ddtWHdgtFge6-aZ6TPf2x9LjfuSsYhS0JzERnGOwbvfg0QetnWQUPTKAtuuGuc06zYymCUfPon9f_jZfdZ2rsQPFSP3RAstyJ8QMmtCOVOhBH24ekkj6AH1bG_kkrbRQ</recordid><startdate>20230517</startdate><enddate>20230517</enddate><creator>Ridgway, Jessica P</creator><creator>Devlin, Samantha A</creator><creator>Friedman, Eleanor E</creator><creator>Enaholo, Ososese E</creator><creator>Pyra, Maria</creator><creator>Hirschhorn, Lisa R</creator><creator>Haider, Sadia</creator><creator>Ducheny, Kelly</creator><creator>Johnson, Amy K</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2090-9620</orcidid></search><sort><creationdate>20230517</creationdate><title>POWER Up-Improving pre-exposure prophylaxis (PrEP) uptake among Black cisgender women in the Southern United States: Protocol for a stepped-wedge cluster randomized trial (SW-CRT)</title><author>Ridgway, Jessica P ; Devlin, Samantha A ; Friedman, Eleanor E ; Enaholo, Ososese E ; Pyra, Maria ; Hirschhorn, Lisa R ; Haider, Sadia ; Ducheny, Kelly ; Johnson, Amy K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c527t-778101d58c7a71f78904d25e572ed314f2293183c884c1ff5880e835b2be1f133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Acquired Immunodeficiency Syndrome - drug therapy</topic><topic>Adaptation</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Biology and Life Sciences</topic><topic>Black or African American</topic><topic>Black people</topic><topic>Cisgender</topic><topic>Clusters</topic><topic>Computer and Information Sciences</topic><topic>Disease prevention</topic><topic>Disease transmission</topic><topic>Effectiveness</topic><topic>Electronic health records</topic><topic>Electronic medical records</topic><topic>Engineering and Technology</topic><topic>Female</topic><topic>Health care networks</topic><topic>Health risks</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - prevention & control</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Medicine and Health Sciences</topic><topic>Optimization</topic><topic>Patients</topic><topic>Pre-Exposure Prophylaxis - methods</topic><topic>Prophylaxis</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Study Protocol</topic><topic>United States</topic><topic>Utilization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ridgway, Jessica P</creatorcontrib><creatorcontrib>Devlin, Samantha A</creatorcontrib><creatorcontrib>Friedman, Eleanor E</creatorcontrib><creatorcontrib>Enaholo, Ososese E</creatorcontrib><creatorcontrib>Pyra, Maria</creatorcontrib><creatorcontrib>Hirschhorn, Lisa R</creatorcontrib><creatorcontrib>Haider, Sadia</creatorcontrib><creatorcontrib>Ducheny, Kelly</creatorcontrib><creatorcontrib>Johnson, Amy K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ridgway, Jessica P</au><au>Devlin, Samantha A</au><au>Friedman, Eleanor E</au><au>Enaholo, Ososese E</au><au>Pyra, Maria</au><au>Hirschhorn, Lisa R</au><au>Haider, Sadia</au><au>Ducheny, Kelly</au><au>Johnson, Amy K</au><au>Stortz, Johannes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>POWER Up-Improving pre-exposure prophylaxis (PrEP) uptake among Black cisgender women in the Southern United States: Protocol for a stepped-wedge cluster randomized trial (SW-CRT)</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2023-05-17</date><risdate>2023</risdate><volume>18</volume><issue>5</issue><spage>e0285858</spage><epage>e0285858</epage><pages>e0285858-e0285858</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>HIV disproportionately affects Black/African American cisgender women (hereafter women) in the United States. Despite its proven effectiveness, pre-exposure prophylaxis (PrEP) for HIV prevention remains vastly under-prescribed to women based on their need. Increasing PrEP uptake and persistence among women is crucial to reducing HIV transmission; however, there have been few studies designed specifically for women. This article describes the study protocol used to assess the feasibility, acceptability, and effectiveness of implementation strategies to improve PrEP uptake and persistence among Black women in the Midwest and South.
PrEP Optimization among Women to Enhance Retention and Uptake (POWER Up) is an evidence-based, woman-focused set of five implementation science strategies that addresses barriers of PrEP utilization at the provider, patient, and clinic levels. POWER Up includes 1) routine PrEP education for patients, 2) standardized provider training, 3) electronic medical record (EMR) optimization, 4) PrEP navigation, and 5) PrEP clinical champions. These strategies will be adapted to specific clinics for implementation, tested via a stepped-wedge trial, and, if effective, packaged for further dissemination.
We will utilize a stepped-wedge cluster randomized trial (SW-CRT) to measure change in PrEP utilization across diverse geographic areas. Preparation for adapting and implementing the bundle of strategies is needed to determine how to tailor them to specific clinics. Implementation challenges will include adapting strategies with the available resources at each site, maintaining stakeholder involvement and staff buy-in, adjusting the study protocol and planned procedures as needed, and ensuring minimal crossover. Additionally, strengths and limitations of each strategy must be examined before, during, and after the adaptation and implementation processes. Finally, the implementation outcomes of the strategies must be evaluated to determine the real-world success of the strategies. This study is an important step toward addressing the inequity in PrEP service delivery and increasing PrEP utilization among Black women in the U.S.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>37196008</pmid><doi>10.1371/journal.pone.0285858</doi><orcidid>https://orcid.org/0000-0002-2090-9620</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2023-05, Vol.18 (5), p.e0285858-e0285858 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_2814793279 |
source | PubMed Central Free; Publicly Available Content Database |
subjects | Acquired Immunodeficiency Syndrome - drug therapy Adaptation Anti-HIV Agents - therapeutic use Biology and Life Sciences Black or African American Black people Cisgender Clusters Computer and Information Sciences Disease prevention Disease transmission Effectiveness Electronic health records Electronic medical records Engineering and Technology Female Health care networks Health risks HIV HIV Infections - drug therapy HIV Infections - prevention & control Human immunodeficiency virus Humans Medicine and Health Sciences Optimization Patients Pre-Exposure Prophylaxis - methods Prophylaxis Randomized Controlled Trials as Topic Study Protocol United States Utilization |
title | POWER Up-Improving pre-exposure prophylaxis (PrEP) uptake among Black cisgender women in the Southern United States: Protocol for a stepped-wedge cluster randomized trial (SW-CRT) |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A01%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=POWER%20Up-Improving%20pre-exposure%20prophylaxis%20(PrEP)%20uptake%20among%20Black%20cisgender%20women%20in%20the%20Southern%20United%20States:%20Protocol%20for%20a%20stepped-wedge%20cluster%20randomized%20trial%20(SW-CRT)&rft.jtitle=PloS%20one&rft.au=Ridgway,%20Jessica%20P&rft.date=2023-05-17&rft.volume=18&rft.issue=5&rft.spage=e0285858&rft.epage=e0285858&rft.pages=e0285858-e0285858&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0285858&rft_dat=%3Cproquest_plos_%3E2815247005%3C/proquest_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c527t-778101d58c7a71f78904d25e572ed314f2293183c884c1ff5880e835b2be1f133%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2814793279&rft_id=info:pmid/37196008&rfr_iscdi=true |